Product Details

Linezolid (Lyophilized) for Injection BP is manufactured to strict BP-standard specifications for use in the treatment of serious bacterial infections. It is prescribed for patients requiring hospital-based antibiotic therapy.

The injection combines:

• Linezolid — an oxazolidinone antibiotic that inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit, preventing formation of the functional ribosomal complex

Linezolid (Lyophilized) for Injection BP is indicated in the treatment of serious infections caused by Gram-positive bacteria, including MRSA and vancomycin-resistant Enterococcus (VRE). As a result, it is administered under medical supervision, typically in hospital wards and intensive care settings.

Key Features:

• Manufactured to BP-standard compliance for consistent quality
• Lyophilized sterile powder ensures stability before reconstitution
• Accurate potency per vial supports precise dosing in antibiotic therapy
• Supplied with Sterile Water for Injection for convenient reconstitution
• Single Dose Vial format minimizes contamination risk
• Suitable for hospital pharmacies and institutional supply